Yangyang Xu Selected Research

Immunotherapy

1/2024	Molecular and immunological features of TREM1 and its emergence as a prognostic indicator in glioma.
3/2023	Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer.
1/2021	The Predictive Value of Clinical and Molecular Characteristics or Immunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.
11/2020	[Immunotherapy Advances in Small Cell Lung Cancer].
11/2020	MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8+ T lymphocytes in human diffuse large B cell lymphoma.
8/2019	The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yangyang Xu Research Topics

Disease

32	Neoplasms (Cancer) 03/2024 - 10/2013
9	Glioma (Gliomas) 01/2024 - 09/2013
7	Infections 01/2023 - 05/2018
6	Renal Cell Carcinoma (Grawitz Tumor) 03/2023 - 10/2013
6	Glioblastoma (Glioblastoma Multiforme) 09/2021 - 01/2017
5	Inflammation (Inflammations) 03/2024 - 04/2018
5	Neoplasm Metastasis (Metastasis) 09/2023 - 01/2014
4	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2022
4	Hypoxia (Hypoxemia) 07/2021 - 08/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 04/2019
3	Scoliosis 10/2023 - 01/2022
3	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 05/2013
3	Fatigue 01/2023 - 09/2022
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023 - 01/2016
3	Infarction (Infarctions) 01/2023 - 01/2021
3	Breast Neoplasms (Breast Cancer) 12/2021 - 10/2017
2	Osteoarthritis 12/2023 - 07/2023
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 11/2023 - 01/2022
2	Bites and Stings (Sting) 09/2023 - 01/2023
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2023 - 05/2014
2	Brain Ischemia (Cerebral Ischemia) 01/2023 - 01/2021
2	Neuroinflammatory Diseases 01/2023 - 01/2023
2	Reperfusion Injury 01/2023 - 01/2021
2	Ischemia 01/2023 - 01/2016
2	Pathologic Constriction (Stenosis) 01/2023 - 10/2021
2	COVID-19 11/2022 - 01/2020
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022 - 07/2020
2	Body Weight (Weight, Body) 11/2021 - 08/2021
2	Lung Neoplasms (Lung Cancer) 03/2021 - 08/2019
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 08/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2020 - 12/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2020 - 04/2019
2	IGA Glomerulonephritis (IGA Nephropathy) 06/2020 - 12/2017
2	Necrosis 04/2020 - 11/2019
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2019 - 04/2018
2	Diarrhea 03/2019 - 04/2018
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2019 - 06/2018
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 10/2018
2	Carcinogenesis 01/2014 - 10/2013
1	Hyperplasia 03/2024
1	Ischemic Stroke 12/2023
1	Chronic Pain 09/2023
1	Pain (Aches) 09/2023
1	Stomach Neoplasms (Stomach Cancer) 03/2023
1	Hepatocellular Carcinoma (Hepatoma) 03/2023
1	Pituitary ACTH Hypersecretion 02/2023
1	Low Back Pain (Lumbago) 01/2023

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2013
4	CytokinesIBA 03/2024 - 04/2015
4	RNA (Ribonucleic Acid)IBA 09/2023 - 01/2018
4	ElementsIBA 01/2023 - 12/2017
4	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2017
3	engeletinIBA 12/2023 - 01/2021
3	Phosphotransferases (Kinase)IBA 10/2022 - 12/2017
3	Galectin 3 (LGALS3)IBA 01/2021 - 10/2013
3	BaizhuIBA 03/2019 - 04/2018
3	Messenger RNA (mRNA)IBA 04/2017 - 05/2014
2	Long Noncoding RNAIBA 03/2024 - 03/2023
2	IronIBA 12/2023 - 01/2018
2	Interferon Type IIBA 09/2023 - 01/2023
2	AlloysIBA 01/2023 - 09/2022
2	InterferonsIBA 01/2023 - 04/2020
2	Glutamic Acid (Glutamate)FDA Link 11/2022 - 10/2022
2	Small Interfering RNA (siRNA)IBA 10/2022 - 04/2017
2	cereulideIBA 11/2021 - 08/2021
2	sepantroniumIBA 09/2021 - 01/2018
2	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 07/2021 - 04/2017
2	salvianolateIBA 05/2021 - 10/2019
2	VaccinesIBA 05/2021 - 10/2020
2	AlbuminsIBA 03/2021 - 02/2021
2	Immune Checkpoint InhibitorsIBA 01/2021 - 08/2019
2	MicroRNAs (MicroRNA)IBA 11/2020 - 08/2014
2	AntigensIBA 10/2020 - 01/2018
2	Immunoglobulin A (IgA)IBA 06/2020 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 02/2020 - 08/2019
2	UbiquitinIBA 02/2014 - 01/2014
1	AndrogensIBA 03/2024
1	Antisense RNA (Anti-Sense RNA)IBA 03/2024
1	Calcium-Binding ProteinsIBA 03/2024
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	Therapeutic UsesIBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 09/2023
1	SterolsIBA 07/2023
1	Carrier Proteins (Binding Protein)IBA 07/2023
1	LipidsIBA 07/2023
1	AntioxidantsIBA 06/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2023
1	Vitamin D FDA LinkGeneric 06/2023
1	TeaIBA 06/2023
1	Vitamin B 6IBA 06/2023

Therapy/Procedure

13	Therapeutics 03/2024 - 04/2015
6	Immunotherapy 01/2024 - 08/2019
4	Radiotherapy 01/2021 - 01/2017
4	Drug Therapy (Chemotherapy) 01/2021 - 10/2013
3	Deep Brain Stimulation 11/2023 - 01/2022
2	Contact Lenses 01/2022 - 07/2020
1	Castration 03/2024
1	Osteotomy 10/2023
1	Nephrectomy 07/2023